CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Non applicableWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug458 Eculizumab Wiki 0.71

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis - Serology

This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Santé cohorts.

NCT04392388 SARS-CoV 2 Biological: Non applicable

Primary Outcomes

Description: To assess the cumulative incidence of SARS-Cov2 infection in the general population.

Measure: Cumulative incidence of SARS-Cov2 infection in the general population.

Time: 8 months

Secondary Outcomes

Description: Besides to Characterize the "immune" fraction of the population and the durability of immunity, the other secondary outcomes are: Identify associations of predictive symptoms of SARS-Cov2 infection Estimate the use of care rate in connection with a SARS-Cov2 infection Estimate the fraction of sub-clinical infections or infections not captured by the healthcare system; Study the acceptability of a mass anti-SARS-Cov2 serological test and the impact of its result, link with social inequalities in health; Estimate the individual and collective impact of containment and other barrier measures on the risk of seroconversion; Study the impact of social and territorial inequalities on the level of seroprevalence.

Measure: Characterize the "immune" fraction of the population and the durability of immunity

Time: 8 months


No related HPO nodes (Using clinical trials)